wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33710179-60FFF56E-84AE-4CF9-9090-D58D054AC93D
Q33710179-60FFF56E-84AE-4CF9-9090-D58D054AC93D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33710179-60FFF56E-84AE-4CF9-9090-D58D054AC93D
Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy
P2860
Q33710179-60FFF56E-84AE-4CF9-9090-D58D054AC93D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33710179-60FFF56E-84AE-4CF9-9090-D58D054AC93D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ab46a695a28c83c6d615d73df9530fe062b82527
P2860
Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer.